3 Biotech Stocks That Actually Pay Dividends and Keep Raising Them
Published . Updated .
Key takeaways
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
Biotech usually torches cash and dilutes shareholders to fund the next trial. Three drugmakers flip that script, and the one with the smallest yield may be hiding the sturdiest payout of all. Coverage, not yield, tells the real story.
Directly affected
- No company is named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “biotech” (pharma and health) in this story.
- XBI SPDR S&P Biotech ETF
SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “biotech” (pharma and health) in this story.
- LLY Eli Lilly and+19.1% 30d
Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “biotech” (pharma and health) in this story.
- JNJ Johnson & Johnson+6.5% 30d
Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “biotech” (pharma and health) in this story.
- PFE Pfizer+2.5% 30d
Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “biotech” (pharma and health) in this story.
- MRK Merck+4.8% 30d
Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “biotech” (pharma and health) in this story.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| XLV | -2.31% | -1.80% | base | after close | after close | after close | after close |
| XBI | -1.25% | -5.41% | base | after close | after close | after close | after close |
| LLY | -0.21% | -3.19% | base | after close | after close | after close | after close |
| JNJ | -5.66% | -3.43% | base | after close | after close | after close | after close |
| PFE | +2.51% | +2.17% | base | after close | after close | after close | after close |
| MRK | -2.73% | -1.23% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
3 Biotech Stocks That Actually Pay Dividends and Keep Raising Them 24/7 Wall St.
Source: 24/7 Wall St.
The price since 10 Nov 2026: Select Sector Spdr Tr (XLV) versus the S&P 500
| Company | When | Move | Status |
|---|---|---|---|
| Johnson & Johnson (JNJ) | three days earlier | -3.43% | final price |
| Johnson & Johnson (JNJ) | five days earlier | -5.66% | final price |
| Eli Lilly (LLY) | three days earlier | -3.19% | final price |
| Eli Lilly (LLY) | five days earlier | -0.21% | final price |
| Merck (MRK) | three days earlier | -1.23% | final price |
| Merck (MRK) | five days earlier | -2.73% | final price |
| Pfizer (PFE) | three days earlier | +2.17% | final price |
| Pfizer (PFE) | five days earlier | +2.51% | final price |
| Spdr Series Trust (XBI) | three days earlier | -5.41% | final price |
| Spdr Series Trust (XBI) | five days earlier | -1.25% | final price |
| Select Sector Spdr Tr (XLV) | three days earlier | -1.80% | final price |
| Select Sector Spdr Tr (XLV) | five days earlier | -2.31% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 67 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Johnson & Johnson (JNJ) (held by a spouse), worth $15,001 - $50,000 on 7 Oct 2026. That is 34 days before publication. Filed 5 Nov 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 41 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 46 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Pfizer (PFE) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 67 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Pfizer (PFE), worth $100,001 - $250,000 on 21 Aug 2026. That is 81 days before publication. Filed 8 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 47 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 83 days before publication. Filed 9 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Select Sector Spdr Tr (XLV)
Companies tied to this story
- XLV Select Sector Spdr Tr
For “3 Biotech Stocks That Actually Pay Dividends and Keep Raising Them,” Select Sector Spdr Tr (XLV) is linked, with no stored direction, medium confidence. Reason on file: Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “biotech” (pharma and health) in this story
- XBI Spdr Series Trust
In “3 Biotech Stocks That Actually Pay Dividends and Keep Raising Them,” Spdr Series Trust (XBI) is linked, with no stored direction, medium confidence. Reason on file: SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “biotech” (pharma and health) in this story
- LLY Eli Lilly
Eli Lilly (LLY) is linked, with no stored direction, medium confidence in the 10 Nov 2026 story “3 Biotech Stocks That Actually Pay Dividends and Keep Raising Them.” Reason on file: Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “biotech” (pharma and health) in this story
- JNJ Johnson & Johnson
In “3 Biotech Stocks That Actually Pay Dividends and Keep Raising Them,” Johnson & Johnson (JNJ) is linked, with no stored direction, medium confidence. Reason on file: Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “biotech” (pharma and health) in this story
- PFE Pfizer
For “3 Biotech Stocks That Actually Pay Dividends and Keep Raising Them,” Pfizer (PFE) is linked, with no stored direction, medium confidence. Reason on file: Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “biotech” (pharma and health) in this story
- MRK Merck
Merck (MRK) is linked, with no stored direction, medium confidence in the 10 Nov 2026 story “3 Biotech Stocks That Actually Pay Dividends and Keep Raising Them.” Reason on file: Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “biotech” (pharma and health) in this story
Select Sector Spdr Tr (XLV)
The 10 Nov 2026 story “3 Biotech Stocks That Actually Pay Dividends and Keep Raising Them” names Select Sector Spdr Tr (XLV) because of this story.
The link for Select Sector Spdr Tr (XLV) is this: Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “biotech” (pharma and health) in this story
A second company, Spdr Series Trust (XBI), is listed for a different reason: SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “biotech” (pharma and health) in this story
Dates in the story, and the Select Sector Spdr Tr (XLV) price range
LLY traded between 1158.27 and 1452.66 across 20 sessions. The latest close on file is 1412.24.
How strong the case is around Select Sector Spdr Tr (XLV)
46 out of 100
“3 Biotech Stocks That Actually Pay Dividends and Keep Raising Them” scores 46 out of 100. The score uses 1 sources, and 6 linked companies.